nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—PPARG—stomach cancer	0.391	0.727	CbGaD
Repaglinide—ALB—stomach cancer	0.147	0.273	CbGaD
Repaglinide—SLCO1B1—Irinotecan—stomach cancer	0.0713	0.271	CbGbCtD
Repaglinide—ALB—Irinotecan—stomach cancer	0.039	0.148	CbGbCtD
Repaglinide—SLCO1B1—Methotrexate—stomach cancer	0.0377	0.143	CbGbCtD
Repaglinide—ALB—Fluorouracil—stomach cancer	0.0375	0.142	CbGbCtD
Repaglinide—CYP2C8—Fluorouracil—stomach cancer	0.0289	0.11	CbGbCtD
Repaglinide—ALB—Methotrexate—stomach cancer	0.0207	0.0785	CbGbCtD
Repaglinide—CYP3A4—Irinotecan—stomach cancer	0.0122	0.0465	CbGbCtD
Repaglinide—CYP3A4—Docetaxel—stomach cancer	0.00896	0.0341	CbGbCtD
Repaglinide—CYP3A4—Doxorubicin—stomach cancer	0.00668	0.0254	CbGbCtD
Repaglinide—PPARG—Topotecan—Irinotecan—stomach cancer	0.00355	1	CbGdCrCtD
Repaglinide—PPARG—blood vessel—stomach cancer	0.0023	0.0741	CbGeAlD
Repaglinide—ALB—gall bladder—stomach cancer	0.00203	0.0654	CbGeAlD
Repaglinide—KCNJ11—hematopoietic system—stomach cancer	0.00174	0.0561	CbGeAlD
Repaglinide—SLCO1B1—hematopoietic system—stomach cancer	0.00142	0.0458	CbGeAlD
Repaglinide—KCNJ11—pancreas—stomach cancer	0.00142	0.0457	CbGeAlD
Repaglinide—ABCC8—smooth muscle tissue—stomach cancer	0.00141	0.0456	CbGeAlD
Repaglinide—ABCC8—pancreas—stomach cancer	0.0013	0.0421	CbGeAlD
Repaglinide—KCNJ11—lymphoid tissue—stomach cancer	0.00122	0.0395	CbGeAlD
Repaglinide—PPARG—hematopoietic system—stomach cancer	0.00122	0.0395	CbGeAlD
Repaglinide—PPARG—epithelium—stomach cancer	0.00112	0.0361	CbGeAlD
Repaglinide—PPARG—smooth muscle tissue—stomach cancer	0.00108	0.0348	CbGeAlD
Repaglinide—KCNJ11—endocrine gland—stomach cancer	0.000999	0.0323	CbGeAlD
Repaglinide—PPARG—pancreas—stomach cancer	0.000995	0.0321	CbGeAlD
Repaglinide—SLCO1B1—digestive system—stomach cancer	0.000985	0.0318	CbGeAlD
Repaglinide—ABCC8—endocrine gland—stomach cancer	0.00092	0.0297	CbGeAlD
Repaglinide—PPARG—lymphoid tissue—stomach cancer	0.00086	0.0278	CbGeAlD
Repaglinide—PPARG—digestive system—stomach cancer	0.00085	0.0275	CbGeAlD
Repaglinide—SLCO1B1—endocrine gland—stomach cancer	0.000814	0.0263	CbGeAlD
Repaglinide—CYP2C8—hematopoietic system—stomach cancer	0.000806	0.026	CbGeAlD
Repaglinide—PPARG—bone marrow—stomach cancer	0.000783	0.0253	CbGeAlD
Repaglinide—SLCO1B1—liver—stomach cancer	0.000734	0.0237	CbGeAlD
Repaglinide—PPARG—endocrine gland—stomach cancer	0.000702	0.0227	CbGeAlD
Repaglinide—KCNJ11—lymph node—stomach cancer	0.00069	0.0223	CbGeAlD
Repaglinide—PPARG—liver—stomach cancer	0.000633	0.0205	CbGeAlD
Repaglinide—ALB—liver—stomach cancer	0.000594	0.0192	CbGeAlD
Repaglinide—CYP3A4—hematopoietic system—stomach cancer	0.000546	0.0176	CbGeAlD
Repaglinide—PPARG—lymph node—stomach cancer	0.000485	0.0157	CbGeAlD
Repaglinide—CYP2C8—endocrine gland—stomach cancer	0.000463	0.015	CbGeAlD
Repaglinide—ALB—lymph node—stomach cancer	0.000455	0.0147	CbGeAlD
Repaglinide—CYP2C8—liver—stomach cancer	0.000417	0.0135	CbGeAlD
Repaglinide—CYP3A4—digestive system—stomach cancer	0.00038	0.0123	CbGeAlD
Repaglinide—CYP3A4—endocrine gland—stomach cancer	0.000314	0.0101	CbGeAlD
Repaglinide—Hepatobiliary disease—Docetaxel—stomach cancer	0.000304	0.00302	CcSEcCtD
Repaglinide—Jaundice—Capecitabine—stomach cancer	0.000303	0.00302	CcSEcCtD
Repaglinide—Urinary tract infection—Capecitabine—stomach cancer	0.000302	0.00301	CcSEcCtD
Repaglinide—Hepatic function abnormal—Doxorubicin—stomach cancer	0.000298	0.00296	CcSEcCtD
Repaglinide—Anaphylactic shock—Irinotecan—stomach cancer	0.000296	0.00295	CcSEcCtD
Repaglinide—Oedema—Irinotecan—stomach cancer	0.000296	0.00295	CcSEcCtD
Repaglinide—Chest pain—Fluorouracil—stomach cancer	0.000296	0.00295	CcSEcCtD
Repaglinide—Hepatobiliary disease—Capecitabine—stomach cancer	0.000294	0.00293	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Epirubicin—stomach cancer	0.000291	0.00289	CcSEcCtD
Repaglinide—Thrombocytopenia—Irinotecan—stomach cancer	0.00029	0.00289	CcSEcCtD
Repaglinide—Rhinitis—Docetaxel—stomach cancer	0.000289	0.00288	CcSEcCtD
Repaglinide—Hepatitis—Docetaxel—stomach cancer	0.000288	0.00287	CcSEcCtD
Repaglinide—Hypoglycaemia—Epirubicin—stomach cancer	0.000288	0.00287	CcSEcCtD
Repaglinide—Cardiac failure congestive—Doxorubicin—stomach cancer	0.000287	0.00285	CcSEcCtD
Repaglinide—Oedema peripheral—Docetaxel—stomach cancer	0.000284	0.00283	CcSEcCtD
Repaglinide—Oedema—Fluorouracil—stomach cancer	0.000284	0.00282	CcSEcCtD
Repaglinide—Anaphylactic shock—Fluorouracil—stomach cancer	0.000284	0.00282	CcSEcCtD
Repaglinide—CYP3A4—liver—stomach cancer	0.000283	0.00913	CbGeAlD
Repaglinide—Rhinitis—Capecitabine—stomach cancer	0.00028	0.00278	CcSEcCtD
Repaglinide—Hepatitis—Capecitabine—stomach cancer	0.000279	0.00278	CcSEcCtD
Repaglinide—Thrombocytopenia—Fluorouracil—stomach cancer	0.000278	0.00277	CcSEcCtD
Repaglinide—Visual impairment—Docetaxel—stomach cancer	0.000278	0.00277	CcSEcCtD
Repaglinide—Oedema peripheral—Capecitabine—stomach cancer	0.000275	0.00274	CcSEcCtD
Repaglinide—Erythema multiforme—Docetaxel—stomach cancer	0.000273	0.00271	CcSEcCtD
Repaglinide—Eye disorder—Docetaxel—stomach cancer	0.00027	0.00268	CcSEcCtD
Repaglinide—Visual impairment—Capecitabine—stomach cancer	0.000269	0.00268	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Doxorubicin—stomach cancer	0.000269	0.00267	CcSEcCtD
Repaglinide—Cardiac disorder—Docetaxel—stomach cancer	0.000268	0.00266	CcSEcCtD
Repaglinide—Hypoglycaemia—Doxorubicin—stomach cancer	0.000267	0.00265	CcSEcCtD
Repaglinide—Paraesthesia—Irinotecan—stomach cancer	0.000266	0.00265	CcSEcCtD
Repaglinide—Erythema multiforme—Capecitabine—stomach cancer	0.000264	0.00263	CcSEcCtD
Repaglinide—Eye disorder—Capecitabine—stomach cancer	0.000261	0.0026	CcSEcCtD
Repaglinide—Dyspepsia—Irinotecan—stomach cancer	0.000261	0.0026	CcSEcCtD
Repaglinide—Immune system disorder—Docetaxel—stomach cancer	0.000261	0.00259	CcSEcCtD
Repaglinide—Cardiac disorder—Capecitabine—stomach cancer	0.000259	0.00258	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000259	0.00257	CcSEcCtD
Repaglinide—Arrhythmia—Docetaxel—stomach cancer	0.000258	0.00256	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000256	0.00255	CcSEcCtD
Repaglinide—Paraesthesia—Fluorouracil—stomach cancer	0.000255	0.00254	CcSEcCtD
Repaglinide—Alopecia—Docetaxel—stomach cancer	0.000255	0.00254	CcSEcCtD
Repaglinide—Pancreatitis—Methotrexate—stomach cancer	0.000255	0.00253	CcSEcCtD
Repaglinide—Constipation—Irinotecan—stomach cancer	0.000254	0.00252	CcSEcCtD
Repaglinide—Immune system disorder—Capecitabine—stomach cancer	0.000252	0.00251	CcSEcCtD
Repaglinide—Erythema—Docetaxel—stomach cancer	0.000251	0.0025	CcSEcCtD
Repaglinide—Malnutrition—Docetaxel—stomach cancer	0.000251	0.0025	CcSEcCtD
Repaglinide—Dyspepsia—Fluorouracil—stomach cancer	0.00025	0.00249	CcSEcCtD
Repaglinide—Arrhythmia—Capecitabine—stomach cancer	0.00025	0.00248	CcSEcCtD
Repaglinide—Alopecia—Capecitabine—stomach cancer	0.000247	0.00245	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000245	0.00244	CcSEcCtD
Repaglinide—Malnutrition—Capecitabine—stomach cancer	0.000243	0.00242	CcSEcCtD
Repaglinide—Erythema—Capecitabine—stomach cancer	0.000243	0.00242	CcSEcCtD
Repaglinide—Back pain—Docetaxel—stomach cancer	0.000243	0.00242	CcSEcCtD
Repaglinide—Gastrointestinal pain—Irinotecan—stomach cancer	0.000242	0.00241	CcSEcCtD
Repaglinide—Pancreatitis—Epirubicin—stomach cancer	0.000238	0.00237	CcSEcCtD
Repaglinide—Angina pectoris—Epirubicin—stomach cancer	0.000237	0.00236	CcSEcCtD
Repaglinide—Back pain—Capecitabine—stomach cancer	0.000235	0.00234	CcSEcCtD
Repaglinide—Abdominal pain—Irinotecan—stomach cancer	0.000234	0.00233	CcSEcCtD
Repaglinide—Bronchitis—Epirubicin—stomach cancer	0.000234	0.00233	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.00023	0.00228	CcSEcCtD
Repaglinide—Urticaria—Fluorouracil—stomach cancer	0.000226	0.00224	CcSEcCtD
Repaglinide—Leukopenia—Docetaxel—stomach cancer	0.000225	0.00224	CcSEcCtD
Repaglinide—Palpitations—Docetaxel—stomach cancer	0.000222	0.00221	CcSEcCtD
Repaglinide—Pancreatitis—Doxorubicin—stomach cancer	0.000221	0.00219	CcSEcCtD
Repaglinide—Hyperglycaemia—Epirubicin—stomach cancer	0.000219	0.00218	CcSEcCtD
Repaglinide—Angina pectoris—Doxorubicin—stomach cancer	0.000219	0.00218	CcSEcCtD
Repaglinide—Hepatobiliary disease—Methotrexate—stomach cancer	0.000219	0.00218	CcSEcCtD
Repaglinide—Hypersensitivity—Irinotecan—stomach cancer	0.000218	0.00217	CcSEcCtD
Repaglinide—Leukopenia—Capecitabine—stomach cancer	0.000218	0.00216	CcSEcCtD
Repaglinide—Hypertension—Docetaxel—stomach cancer	0.000217	0.00216	CcSEcCtD
Repaglinide—Bronchitis—Doxorubicin—stomach cancer	0.000216	0.00215	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.000215	0.00214	CcSEcCtD
Repaglinide—Palpitations—Capecitabine—stomach cancer	0.000215	0.00214	CcSEcCtD
Repaglinide—Chest pain—Docetaxel—stomach cancer	0.000214	0.00213	CcSEcCtD
Repaglinide—Arthralgia—Docetaxel—stomach cancer	0.000214	0.00213	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000212	0.00211	CcSEcCtD
Repaglinide—Jaundice—Epirubicin—stomach cancer	0.000211	0.0021	CcSEcCtD
Repaglinide—Urinary tract infection—Epirubicin—stomach cancer	0.000211	0.0021	CcSEcCtD
Repaglinide—Hypertension—Capecitabine—stomach cancer	0.00021	0.00209	CcSEcCtD
Repaglinide—Hypersensitivity—Fluorouracil—stomach cancer	0.000209	0.00208	CcSEcCtD
Repaglinide—Hepatitis—Methotrexate—stomach cancer	0.000208	0.00207	CcSEcCtD
Repaglinide—Arthralgia—Capecitabine—stomach cancer	0.000207	0.00206	CcSEcCtD
Repaglinide—Chest pain—Capecitabine—stomach cancer	0.000207	0.00206	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000206	0.00204	CcSEcCtD
Repaglinide—Hepatobiliary disease—Epirubicin—stomach cancer	0.000205	0.00204	CcSEcCtD
Repaglinide—Oedema—Docetaxel—stomach cancer	0.000205	0.00204	CcSEcCtD
Repaglinide—Anaphylactic shock—Docetaxel—stomach cancer	0.000205	0.00204	CcSEcCtD
Repaglinide—Sinusitis—Epirubicin—stomach cancer	0.000203	0.00202	CcSEcCtD
Repaglinide—Hyperglycaemia—Doxorubicin—stomach cancer	0.000203	0.00202	CcSEcCtD
Repaglinide—Diarrhoea—Irinotecan—stomach cancer	0.000203	0.00202	CcSEcCtD
Repaglinide—Pruritus—Fluorouracil—stomach cancer	0.000201	0.002	CcSEcCtD
Repaglinide—Thrombocytopenia—Docetaxel—stomach cancer	0.000201	0.002	CcSEcCtD
Repaglinide—Visual impairment—Methotrexate—stomach cancer	0.0002	0.00199	CcSEcCtD
Repaglinide—Skin disorder—Docetaxel—stomach cancer	0.000199	0.00198	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000199	0.00198	CcSEcCtD
Repaglinide—Oedema—Capecitabine—stomach cancer	0.000198	0.00197	CcSEcCtD
Repaglinide—Erythema multiforme—Methotrexate—stomach cancer	0.000197	0.00196	CcSEcCtD
Repaglinide—Jaundice—Doxorubicin—stomach cancer	0.000195	0.00194	CcSEcCtD
Repaglinide—Rhinitis—Epirubicin—stomach cancer	0.000195	0.00194	CcSEcCtD
Repaglinide—Urinary tract infection—Doxorubicin—stomach cancer	0.000195	0.00194	CcSEcCtD
Repaglinide—Hepatitis—Epirubicin—stomach cancer	0.000195	0.00194	CcSEcCtD
Repaglinide—Eye disorder—Methotrexate—stomach cancer	0.000194	0.00193	CcSEcCtD
Repaglinide—Diarrhoea—Fluorouracil—stomach cancer	0.000194	0.00193	CcSEcCtD
Repaglinide—Thrombocytopenia—Capecitabine—stomach cancer	0.000194	0.00193	CcSEcCtD
Repaglinide—Cardiac disorder—Methotrexate—stomach cancer	0.000193	0.00192	CcSEcCtD
Repaglinide—Skin disorder—Capecitabine—stomach cancer	0.000193	0.00192	CcSEcCtD
Repaglinide—Oedema peripheral—Epirubicin—stomach cancer	0.000192	0.00191	CcSEcCtD
Repaglinide—Hepatobiliary disease—Doxorubicin—stomach cancer	0.00019	0.00189	CcSEcCtD
Repaglinide—Vomiting—Irinotecan—stomach cancer	0.000189	0.00187	CcSEcCtD
Repaglinide—Sinusitis—Doxorubicin—stomach cancer	0.000188	0.00187	CcSEcCtD
Repaglinide—Immune system disorder—Methotrexate—stomach cancer	0.000188	0.00187	CcSEcCtD
Repaglinide—Visual impairment—Epirubicin—stomach cancer	0.000188	0.00187	CcSEcCtD
Repaglinide—Rash—Irinotecan—stomach cancer	0.000187	0.00186	CcSEcCtD
Repaglinide—Dermatitis—Irinotecan—stomach cancer	0.000187	0.00186	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000187	0.00186	CcSEcCtD
Repaglinide—Headache—Irinotecan—stomach cancer	0.000186	0.00185	CcSEcCtD
Repaglinide—Paraesthesia—Docetaxel—stomach cancer	0.000184	0.00183	CcSEcCtD
Repaglinide—Erythema multiforme—Epirubicin—stomach cancer	0.000184	0.00183	CcSEcCtD
Repaglinide—Alopecia—Methotrexate—stomach cancer	0.000184	0.00183	CcSEcCtD
Repaglinide—Eye disorder—Epirubicin—stomach cancer	0.000182	0.00181	CcSEcCtD
Repaglinide—Malnutrition—Methotrexate—stomach cancer	0.000181	0.0018	CcSEcCtD
Repaglinide—Erythema—Methotrexate—stomach cancer	0.000181	0.0018	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000181	0.0018	CcSEcCtD
Repaglinide—Cardiac disorder—Epirubicin—stomach cancer	0.000181	0.0018	CcSEcCtD
Repaglinide—Vomiting—Fluorouracil—stomach cancer	0.000181	0.0018	CcSEcCtD
Repaglinide—Rhinitis—Doxorubicin—stomach cancer	0.00018	0.0018	CcSEcCtD
Repaglinide—Dyspepsia—Docetaxel—stomach cancer	0.00018	0.00179	CcSEcCtD
Repaglinide—Hepatitis—Doxorubicin—stomach cancer	0.00018	0.00179	CcSEcCtD
Repaglinide—Rash—Fluorouracil—stomach cancer	0.000179	0.00178	CcSEcCtD
Repaglinide—Dermatitis—Fluorouracil—stomach cancer	0.000179	0.00178	CcSEcCtD
Repaglinide—Paraesthesia—Capecitabine—stomach cancer	0.000178	0.00177	CcSEcCtD
Repaglinide—Headache—Fluorouracil—stomach cancer	0.000178	0.00177	CcSEcCtD
Repaglinide—Oedema peripheral—Doxorubicin—stomach cancer	0.000177	0.00176	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000177	0.00176	CcSEcCtD
Repaglinide—Nausea—Irinotecan—stomach cancer	0.000176	0.00175	CcSEcCtD
Repaglinide—Immune system disorder—Epirubicin—stomach cancer	0.000176	0.00175	CcSEcCtD
Repaglinide—Constipation—Docetaxel—stomach cancer	0.000175	0.00174	CcSEcCtD
Repaglinide—Back pain—Methotrexate—stomach cancer	0.000175	0.00174	CcSEcCtD
Repaglinide—Dyspepsia—Capecitabine—stomach cancer	0.000175	0.00174	CcSEcCtD
Repaglinide—Arrhythmia—Epirubicin—stomach cancer	0.000174	0.00173	CcSEcCtD
Repaglinide—Visual impairment—Doxorubicin—stomach cancer	0.000174	0.00173	CcSEcCtD
Repaglinide—Alopecia—Epirubicin—stomach cancer	0.000172	0.00171	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000171	0.0017	CcSEcCtD
Repaglinide—Erythema multiforme—Doxorubicin—stomach cancer	0.00017	0.00169	CcSEcCtD
Repaglinide—Constipation—Capecitabine—stomach cancer	0.00017	0.00169	CcSEcCtD
Repaglinide—Erythema—Epirubicin—stomach cancer	0.000169	0.00168	CcSEcCtD
Repaglinide—Malnutrition—Epirubicin—stomach cancer	0.000169	0.00168	CcSEcCtD
Repaglinide—Nausea—Fluorouracil—stomach cancer	0.000169	0.00168	CcSEcCtD
Repaglinide—Eye disorder—Doxorubicin—stomach cancer	0.000168	0.00167	CcSEcCtD
Repaglinide—Gastrointestinal pain—Docetaxel—stomach cancer	0.000168	0.00167	CcSEcCtD
Repaglinide—Cardiac disorder—Doxorubicin—stomach cancer	0.000167	0.00166	CcSEcCtD
Repaglinide—Back pain—Epirubicin—stomach cancer	0.000164	0.00163	CcSEcCtD
Repaglinide—Immune system disorder—Doxorubicin—stomach cancer	0.000163	0.00162	CcSEcCtD
Repaglinide—Gastrointestinal pain—Capecitabine—stomach cancer	0.000162	0.00161	CcSEcCtD
Repaglinide—Abdominal pain—Docetaxel—stomach cancer	0.000162	0.00161	CcSEcCtD
Repaglinide—Leukopenia—Methotrexate—stomach cancer	0.000162	0.00161	CcSEcCtD
Repaglinide—Arrhythmia—Doxorubicin—stomach cancer	0.000161	0.0016	CcSEcCtD
Repaglinide—Alopecia—Doxorubicin—stomach cancer	0.000159	0.00158	CcSEcCtD
Repaglinide—Urticaria—Capecitabine—stomach cancer	0.000158	0.00157	CcSEcCtD
Repaglinide—Abdominal pain—Capecitabine—stomach cancer	0.000157	0.00156	CcSEcCtD
Repaglinide—Erythema—Doxorubicin—stomach cancer	0.000157	0.00156	CcSEcCtD
Repaglinide—Malnutrition—Doxorubicin—stomach cancer	0.000157	0.00156	CcSEcCtD
Repaglinide—Chest pain—Methotrexate—stomach cancer	0.000154	0.00153	CcSEcCtD
Repaglinide—Arthralgia—Methotrexate—stomach cancer	0.000154	0.00153	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000153	0.00152	CcSEcCtD
Repaglinide—Leukopenia—Epirubicin—stomach cancer	0.000152	0.00151	CcSEcCtD
Repaglinide—Back pain—Doxorubicin—stomach cancer	0.000152	0.00151	CcSEcCtD
Repaglinide—Hypersensitivity—Docetaxel—stomach cancer	0.000151	0.0015	CcSEcCtD
Repaglinide—Palpitations—Epirubicin—stomach cancer	0.00015	0.00149	CcSEcCtD
Repaglinide—Anaphylactic shock—Methotrexate—stomach cancer	0.000148	0.00147	CcSEcCtD
Repaglinide—Hypertension—Epirubicin—stomach cancer	0.000146	0.00145	CcSEcCtD
Repaglinide—Hypersensitivity—Capecitabine—stomach cancer	0.000146	0.00145	CcSEcCtD
Repaglinide—Pruritus—Docetaxel—stomach cancer	0.000145	0.00144	CcSEcCtD
Repaglinide—Thrombocytopenia—Methotrexate—stomach cancer	0.000145	0.00144	CcSEcCtD
Repaglinide—Chest pain—Epirubicin—stomach cancer	0.000144	0.00143	CcSEcCtD
Repaglinide—Arthralgia—Epirubicin—stomach cancer	0.000144	0.00143	CcSEcCtD
Repaglinide—Skin disorder—Methotrexate—stomach cancer	0.000143	0.00143	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000143	0.00142	CcSEcCtD
Repaglinide—Pruritus—Capecitabine—stomach cancer	0.00014	0.0014	CcSEcCtD
Repaglinide—Leukopenia—Doxorubicin—stomach cancer	0.00014	0.0014	CcSEcCtD
Repaglinide—Diarrhoea—Docetaxel—stomach cancer	0.00014	0.00139	CcSEcCtD
Repaglinide—Palpitations—Doxorubicin—stomach cancer	0.000139	0.00138	CcSEcCtD
Repaglinide—Oedema—Epirubicin—stomach cancer	0.000138	0.00137	CcSEcCtD
Repaglinide—Anaphylactic shock—Epirubicin—stomach cancer	0.000138	0.00137	CcSEcCtD
Repaglinide—Diarrhoea—Capecitabine—stomach cancer	0.000136	0.00135	CcSEcCtD
Repaglinide—Thrombocytopenia—Epirubicin—stomach cancer	0.000135	0.00135	CcSEcCtD
Repaglinide—Hypertension—Doxorubicin—stomach cancer	0.000135	0.00135	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000135	0.00134	CcSEcCtD
Repaglinide—Skin disorder—Epirubicin—stomach cancer	0.000134	0.00134	CcSEcCtD
Repaglinide—Arthralgia—Doxorubicin—stomach cancer	0.000133	0.00133	CcSEcCtD
Repaglinide—Chest pain—Doxorubicin—stomach cancer	0.000133	0.00133	CcSEcCtD
Repaglinide—Paraesthesia—Methotrexate—stomach cancer	0.000133	0.00132	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000133	0.00132	CcSEcCtD
Repaglinide—Vomiting—Docetaxel—stomach cancer	0.00013	0.0013	CcSEcCtD
Repaglinide—Dyspepsia—Methotrexate—stomach cancer	0.00013	0.00129	CcSEcCtD
Repaglinide—Rash—Docetaxel—stomach cancer	0.000129	0.00129	CcSEcCtD
Repaglinide—Dermatitis—Docetaxel—stomach cancer	0.000129	0.00128	CcSEcCtD
Repaglinide—Headache—Docetaxel—stomach cancer	0.000128	0.00128	CcSEcCtD
Repaglinide—Oedema—Doxorubicin—stomach cancer	0.000128	0.00127	CcSEcCtD
Repaglinide—Anaphylactic shock—Doxorubicin—stomach cancer	0.000128	0.00127	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000128	0.00127	CcSEcCtD
Repaglinide—Vomiting—Capecitabine—stomach cancer	0.000126	0.00125	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000126	0.00125	CcSEcCtD
Repaglinide—Thrombocytopenia—Doxorubicin—stomach cancer	0.000125	0.00125	CcSEcCtD
Repaglinide—Rash—Capecitabine—stomach cancer	0.000125	0.00124	CcSEcCtD
Repaglinide—Dermatitis—Capecitabine—stomach cancer	0.000125	0.00124	CcSEcCtD
Repaglinide—Headache—Capecitabine—stomach cancer	0.000124	0.00124	CcSEcCtD
Repaglinide—Skin disorder—Doxorubicin—stomach cancer	0.000124	0.00124	CcSEcCtD
Repaglinide—Paraesthesia—Epirubicin—stomach cancer	0.000124	0.00123	CcSEcCtD
Repaglinide—Nausea—Docetaxel—stomach cancer	0.000122	0.00121	CcSEcCtD
Repaglinide—Dyspepsia—Epirubicin—stomach cancer	0.000122	0.00121	CcSEcCtD
Repaglinide—Gastrointestinal pain—Methotrexate—stomach cancer	0.000121	0.0012	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000119	0.00119	CcSEcCtD
Repaglinide—Constipation—Epirubicin—stomach cancer	0.000118	0.00118	CcSEcCtD
Repaglinide—Nausea—Capecitabine—stomach cancer	0.000118	0.00117	CcSEcCtD
Repaglinide—Urticaria—Methotrexate—stomach cancer	0.000117	0.00117	CcSEcCtD
Repaglinide—Abdominal pain—Methotrexate—stomach cancer	0.000117	0.00116	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000117	0.00116	CcSEcCtD
Repaglinide—Paraesthesia—Doxorubicin—stomach cancer	0.000115	0.00114	CcSEcCtD
Repaglinide—Gastrointestinal pain—Epirubicin—stomach cancer	0.000113	0.00112	CcSEcCtD
Repaglinide—Dyspepsia—Doxorubicin—stomach cancer	0.000113	0.00112	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.00011	0.0011	CcSEcCtD
Repaglinide—Urticaria—Epirubicin—stomach cancer	0.00011	0.00109	CcSEcCtD
Repaglinide—Constipation—Doxorubicin—stomach cancer	0.000109	0.00109	CcSEcCtD
Repaglinide—Abdominal pain—Epirubicin—stomach cancer	0.000109	0.00109	CcSEcCtD
Repaglinide—Hypersensitivity—Methotrexate—stomach cancer	0.000109	0.00108	CcSEcCtD
Repaglinide—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000105	0.00104	CcSEcCtD
Repaglinide—Pruritus—Methotrexate—stomach cancer	0.000105	0.00104	CcSEcCtD
Repaglinide—Hypersensitivity—Epirubicin—stomach cancer	0.000102	0.00101	CcSEcCtD
Repaglinide—Urticaria—Doxorubicin—stomach cancer	0.000102	0.00101	CcSEcCtD
Repaglinide—Abdominal pain—Doxorubicin—stomach cancer	0.000101	0.00101	CcSEcCtD
Repaglinide—Diarrhoea—Methotrexate—stomach cancer	0.000101	0.00101	CcSEcCtD
Repaglinide—Pruritus—Epirubicin—stomach cancer	9.78e-05	0.000973	CcSEcCtD
Repaglinide—Diarrhoea—Epirubicin—stomach cancer	9.46e-05	0.000941	CcSEcCtD
Repaglinide—Hypersensitivity—Doxorubicin—stomach cancer	9.42e-05	0.000937	CcSEcCtD
Repaglinide—Vomiting—Methotrexate—stomach cancer	9.39e-05	0.000934	CcSEcCtD
Repaglinide—Rash—Methotrexate—stomach cancer	9.31e-05	0.000926	CcSEcCtD
Repaglinide—Dermatitis—Methotrexate—stomach cancer	9.31e-05	0.000926	CcSEcCtD
Repaglinide—Headache—Methotrexate—stomach cancer	9.25e-05	0.00092	CcSEcCtD
Repaglinide—Pruritus—Doxorubicin—stomach cancer	9.05e-05	0.0009	CcSEcCtD
Repaglinide—Vomiting—Epirubicin—stomach cancer	8.79e-05	0.000874	CcSEcCtD
Repaglinide—Nausea—Methotrexate—stomach cancer	8.77e-05	0.000873	CcSEcCtD
Repaglinide—Diarrhoea—Doxorubicin—stomach cancer	8.75e-05	0.00087	CcSEcCtD
Repaglinide—Rash—Epirubicin—stomach cancer	8.72e-05	0.000867	CcSEcCtD
Repaglinide—Dermatitis—Epirubicin—stomach cancer	8.71e-05	0.000866	CcSEcCtD
Repaglinide—Headache—Epirubicin—stomach cancer	8.66e-05	0.000861	CcSEcCtD
Repaglinide—Nausea—Epirubicin—stomach cancer	8.21e-05	0.000817	CcSEcCtD
Repaglinide—Vomiting—Doxorubicin—stomach cancer	8.13e-05	0.000809	CcSEcCtD
Repaglinide—Rash—Doxorubicin—stomach cancer	8.06e-05	0.000802	CcSEcCtD
Repaglinide—Dermatitis—Doxorubicin—stomach cancer	8.06e-05	0.000801	CcSEcCtD
Repaglinide—Headache—Doxorubicin—stomach cancer	8.01e-05	0.000797	CcSEcCtD
Repaglinide—Nausea—Doxorubicin—stomach cancer	7.6e-05	0.000756	CcSEcCtD
Repaglinide—PPARG—Developmental Biology—ERBB2—stomach cancer	2.29e-05	0.000361	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—CD44—stomach cancer	2.29e-05	0.00036	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.29e-05	0.00036	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.28e-05	0.000359	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.28e-05	0.000358	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—PPP2R1A—stomach cancer	2.26e-05	0.000355	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CA1—stomach cancer	2.25e-05	0.000354	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—FBP1—stomach cancer	2.25e-05	0.000354	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CKB—stomach cancer	2.25e-05	0.000354	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—NDUFA2—stomach cancer	2.25e-05	0.000354	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ALOX5—stomach cancer	2.25e-05	0.000354	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—GSTM1—stomach cancer	2.25e-05	0.000354	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CKB—stomach cancer	2.24e-05	0.000352	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CA1—stomach cancer	2.24e-05	0.000352	CbGpPWpGaD
Repaglinide—ALB—Metabolism—FBP1—stomach cancer	2.24e-05	0.000352	CbGpPWpGaD
Repaglinide—ALB—Metabolism—NDUFA2—stomach cancer	2.24e-05	0.000352	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—TYMS—stomach cancer	2.23e-05	0.000351	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	2.22e-05	0.000349	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—DPYD—stomach cancer	2.21e-05	0.000348	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—GSTM1—stomach cancer	2.21e-05	0.000347	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—SERPINE1—stomach cancer	2.2e-05	0.000346	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—IL6—stomach cancer	2.19e-05	0.000344	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—TYMS—stomach cancer	2.17e-05	0.000341	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—APOA1—stomach cancer	2.16e-05	0.00034	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GSTM1—stomach cancer	2.14e-05	0.000337	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—RHOA—stomach cancer	2.12e-05	0.000334	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PLIN2—stomach cancer	2.12e-05	0.000333	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PLIN2—stomach cancer	2.1e-05	0.000331	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ACAD8—stomach cancer	2.1e-05	0.000331	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—SMAD4—stomach cancer	2.1e-05	0.00033	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ERCC2—stomach cancer	2.08e-05	0.000327	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CD44—stomach cancer	2.07e-05	0.000325	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CA2—stomach cancer	2.06e-05	0.000324	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CA2—stomach cancer	2.05e-05	0.000322	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ERCC2—stomach cancer	2.01e-05	0.000317	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PGAM1—stomach cancer	2.01e-05	0.000316	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—NT5E—stomach cancer	2.01e-05	0.000316	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.01e-05	0.000315	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2e-05	0.000315	CbGpPWpGaD
Repaglinide—ALB—Metabolism—NT5E—stomach cancer	1.99e-05	0.000314	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PGAM1—stomach cancer	1.99e-05	0.000314	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MMP9—stomach cancer	1.97e-05	0.00031	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GSTT1—stomach cancer	1.96e-05	0.000308	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—MTHFR—stomach cancer	1.95e-05	0.000307	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PPP2R1A—stomach cancer	1.95e-05	0.000307	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYP2A6—stomach cancer	1.93e-05	0.000304	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—ERCC2—stomach cancer	1.91e-05	0.000301	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PLCE1—stomach cancer	1.91e-05	0.000301	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALDH7A1—stomach cancer	1.91e-05	0.000301	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PLCE1—stomach cancer	1.9e-05	0.000299	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ALDH7A1—stomach cancer	1.9e-05	0.000299	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—MTHFR—stomach cancer	1.89e-05	0.000298	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AKR1C3—stomach cancer	1.88e-05	0.000296	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GMPR2—stomach cancer	1.87e-05	0.000295	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—UMPS—stomach cancer	1.83e-05	0.000289	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ENO1—stomach cancer	1.83e-05	0.000288	CbGpPWpGaD
Repaglinide—ALB—Metabolism—UMPS—stomach cancer	1.82e-05	0.000287	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.8e-05	0.000284	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CAV1—stomach cancer	1.8e-05	0.000283	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—APOA1—stomach cancer	1.8e-05	0.000283	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—VEGFA—stomach cancer	1.77e-05	0.000278	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PPP2R1A—stomach cancer	1.76e-05	0.000276	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—STAT3—stomach cancer	1.75e-05	0.000275	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CAV1—stomach cancer	1.75e-05	0.000275	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—APOA1—stomach cancer	1.74e-05	0.000274	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—MYC—stomach cancer	1.73e-05	0.000272	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GSTP1—stomach cancer	1.72e-05	0.000271	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—FYN—stomach cancer	1.72e-05	0.00027	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—ALB—stomach cancer	1.72e-05	0.00027	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—IDH3B—stomach cancer	1.71e-05	0.00027	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SUCLG1—stomach cancer	1.71e-05	0.00027	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PDHA1—stomach cancer	1.71e-05	0.000268	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ECHS1—stomach cancer	1.71e-05	0.000268	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—HMOX1—stomach cancer	1.7e-05	0.000267	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PDHA1—stomach cancer	1.7e-05	0.000267	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ECHS1—stomach cancer	1.7e-05	0.000267	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MAPK3—stomach cancer	1.67e-05	0.000263	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.63e-05	0.000257	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CD44—stomach cancer	1.63e-05	0.000256	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—TYMP—stomach cancer	1.6e-05	0.000252	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—FADS1—stomach cancer	1.6e-05	0.000252	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—TYMS—stomach cancer	1.6e-05	0.000252	CbGpPWpGaD
Repaglinide—ALB—Metabolism—TYMP—stomach cancer	1.59e-05	0.000251	CbGpPWpGaD
Repaglinide—ALB—Metabolism—FADS1—stomach cancer	1.59e-05	0.000251	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NDUFV1—stomach cancer	1.59e-05	0.000251	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NDUFS1—stomach cancer	1.59e-05	0.000251	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MAPK1—stomach cancer	1.59e-05	0.00025	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—EGFR—stomach cancer	1.59e-05	0.00025	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GSTM1—stomach cancer	1.58e-05	0.000249	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PPARG—stomach cancer	1.58e-05	0.000249	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.58e-05	0.000248	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PPARG—stomach cancer	1.54e-05	0.000241	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—TNF—stomach cancer	1.51e-05	0.000238	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—stomach cancer	1.51e-05	0.000238	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—KRAS—stomach cancer	1.5e-05	0.000236	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SREBF2—stomach cancer	1.5e-05	0.000236	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SREBF2—stomach cancer	1.49e-05	0.000235	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ERCC2—stomach cancer	1.49e-05	0.000234	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—RORA—stomach cancer	1.48e-05	0.000233	CbGpPWpGaD
Repaglinide—ALB—Metabolism—RORA—stomach cancer	1.48e-05	0.000232	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PLAU—stomach cancer	1.47e-05	0.000231	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—CAV1—stomach cancer	1.43e-05	0.000225	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	1.43e-05	0.000225	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—APOA1—stomach cancer	1.43e-05	0.000225	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ALB—stomach cancer	1.42e-05	0.000224	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PGLS—stomach cancer	1.42e-05	0.000223	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—BLVRB—stomach cancer	1.42e-05	0.000223	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—MTHFR—stomach cancer	1.4e-05	0.00022	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALDOB—stomach cancer	1.39e-05	0.000219	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PPP2R1A—stomach cancer	1.38e-05	0.000218	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ALDOB—stomach cancer	1.38e-05	0.000217	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ALB—stomach cancer	1.38e-05	0.000217	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PRKCB—stomach cancer	1.36e-05	0.000214	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	1.36e-05	0.000214	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—NOS3—stomach cancer	1.36e-05	0.000214	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GSTP1—stomach cancer	1.36e-05	0.000213	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPAP2A—stomach cancer	1.36e-05	0.000213	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—HMOX1—stomach cancer	1.34e-05	0.00021	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—NOS3—stomach cancer	1.32e-05	0.000208	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—SERPINE1—stomach cancer	1.31e-05	0.000207	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.31e-05	0.000206	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.31e-05	0.000206	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.3e-05	0.000205	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.3e-05	0.000205	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALOX5—stomach cancer	1.29e-05	0.000203	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CAV1—stomach cancer	1.29e-05	0.000203	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—APOA1—stomach cancer	1.29e-05	0.000203	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ALOX5—stomach cancer	1.29e-05	0.000202	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—HRAS—stomach cancer	1.28e-05	0.000201	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—DPYD—stomach cancer	1.27e-05	0.0002	CbGpPWpGaD
Repaglinide—ALB—Metabolism—DPYD—stomach cancer	1.26e-05	0.000199	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—TYMS—stomach cancer	1.26e-05	0.000198	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GSTM1—stomach cancer	1.25e-05	0.000196	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PTGS2—stomach cancer	1.25e-05	0.000196	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—APOA1—stomach cancer	1.24e-05	0.000195	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.23e-05	0.000194	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—IL6—stomach cancer	1.22e-05	0.000192	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CKB—stomach cancer	1.21e-05	0.00019	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CA1—stomach cancer	1.21e-05	0.00019	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.21e-05	0.00019	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—FBP1—stomach cancer	1.21e-05	0.00019	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTGS2—stomach cancer	1.21e-05	0.00019	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	1.18e-05	0.000186	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ERCC2—stomach cancer	1.17e-05	0.000184	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.15e-05	0.000181	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.15e-05	0.00018	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PLIN2—stomach cancer	1.14e-05	0.000179	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—SERPINE1—stomach cancer	1.13e-05	0.000178	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTT1—stomach cancer	1.12e-05	0.000177	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTT1—stomach cancer	1.12e-05	0.000176	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP2A6—stomach cancer	1.11e-05	0.000175	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP2A6—stomach cancer	1.11e-05	0.000174	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CA2—stomach cancer	1.1e-05	0.000174	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—MTHFR—stomach cancer	1.1e-05	0.000173	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—RHOA—stomach cancer	1.09e-05	0.000172	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—NOS3—stomach cancer	1.08e-05	0.00017	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AKR1C3—stomach cancer	1.08e-05	0.00017	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NT5E—stomach cancer	1.08e-05	0.000169	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PGAM1—stomach cancer	1.08e-05	0.000169	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AKR1C3—stomach cancer	1.08e-05	0.000169	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ENO1—stomach cancer	1.05e-05	0.000166	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ENO1—stomach cancer	1.05e-05	0.000165	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.04e-05	0.000163	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PLCE1—stomach cancer	1.03e-05	0.000162	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.03e-05	0.000162	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ALB—stomach cancer	1.02e-05	0.00016	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CAV1—stomach cancer	1.02e-05	0.00016	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—APOA1—stomach cancer	1.01e-05	0.000159	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—UMPS—stomach cancer	9.85e-06	0.000155	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—NOS3—stomach cancer	9.76e-06	0.000153	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	9.71e-06	0.000153	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CD44—stomach cancer	9.35e-06	0.000147	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CD44—stomach cancer	9.29e-06	0.000146	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PDHA1—stomach cancer	9.16e-06	0.000144	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ECHS1—stomach cancer	9.16e-06	0.000144	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	9.07e-06	0.000143	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	9.02e-06	0.000142	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PPARG—stomach cancer	8.93e-06	0.000141	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTGS2—stomach cancer	8.93e-06	0.00014	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—FADS1—stomach cancer	8.61e-06	0.000135	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—TYMP—stomach cancer	8.61e-06	0.000135	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—MAPK3—stomach cancer	8.55e-06	0.000135	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—MYC—stomach cancer	8.32e-06	0.000131	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SREBF2—stomach cancer	8.06e-06	0.000127	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ALB—stomach cancer	8.03e-06	0.000126	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—RORA—stomach cancer	7.97e-06	0.000125	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PPP2R1A—stomach cancer	7.95e-06	0.000125	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PPP2R1A—stomach cancer	7.9e-06	0.000124	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—VEGFA—stomach cancer	7.8e-06	0.000123	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTP1—stomach cancer	7.8e-06	0.000123	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTP1—stomach cancer	7.75e-06	0.000122	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—HMOX1—stomach cancer	7.69e-06	0.000121	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—NOS3—stomach cancer	7.68e-06	0.000121	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CA—stomach cancer	7.66e-06	0.000121	CbGpPWpGaD
Repaglinide—ALB—Metabolism—HMOX1—stomach cancer	7.64e-06	0.00012	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALDOB—stomach cancer	7.46e-06	0.000117	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CA—stomach cancer	7.43e-06	0.000117	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—MAPK3—stomach cancer	7.38e-06	0.000116	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—TYMS—stomach cancer	7.25e-06	0.000114	CbGpPWpGaD
Repaglinide—ALB—Metabolism—TYMS—stomach cancer	7.21e-06	0.000113	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTM1—stomach cancer	7.16e-06	0.000113	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTM1—stomach cancer	7.12e-06	0.000112	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTGS2—stomach cancer	7.03e-06	0.000111	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—MAPK1—stomach cancer	7.02e-06	0.00011	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALOX5—stomach cancer	6.94e-06	0.000109	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—DPYD—stomach cancer	6.83e-06	0.000107	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ERCC2—stomach cancer	6.74e-06	0.000106	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ERCC2—stomach cancer	6.7e-06	0.000105	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—KRAS—stomach cancer	6.63e-06	0.000104	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—MTHFR—stomach cancer	6.33e-06	9.96e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—MTHFR—stomach cancer	6.29e-06	9.9e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CA—stomach cancer	6.09e-06	9.58e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTT1—stomach cancer	6.04e-06	9.49e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP2A6—stomach cancer	5.97e-06	9.38e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TP53—stomach cancer	5.89e-06	9.27e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CAV1—stomach cancer	5.84e-06	9.18e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APOA1—stomach cancer	5.83e-06	9.16e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CAV1—stomach cancer	5.81e-06	9.13e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AKR1C3—stomach cancer	5.8e-06	9.13e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APOA1—stomach cancer	5.79e-06	9.11e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ENO1—stomach cancer	5.66e-06	8.9e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—HRAS—stomach cancer	5.64e-06	8.87e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.58e-06	8.77e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.55e-06	8.72e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CA—stomach cancer	5.49e-06	8.64e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PPARG—stomach cancer	5.13e-06	8.07e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PPARG—stomach cancer	5.1e-06	8.03e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CD44—stomach cancer	5.02e-06	7.89e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALB—stomach cancer	4.62e-06	7.26e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—NOS3—stomach cancer	4.42e-06	6.94e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—NOS3—stomach cancer	4.39e-06	6.9e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CA—stomach cancer	4.32e-06	6.8e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPP2R1A—stomach cancer	4.27e-06	6.71e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTP1—stomach cancer	4.18e-06	6.58e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HMOX1—stomach cancer	4.13e-06	6.49e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTGS2—stomach cancer	4.04e-06	6.35e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTGS2—stomach cancer	4.02e-06	6.32e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—TYMS—stomach cancer	3.89e-06	6.12e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTM1—stomach cancer	3.85e-06	6.05e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ERCC2—stomach cancer	3.62e-06	5.69e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—MTHFR—stomach cancer	3.4e-06	5.34e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CAV1—stomach cancer	3.13e-06	4.93e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOA1—stomach cancer	3.13e-06	4.92e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPARG—stomach cancer	2.76e-06	4.33e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CA—stomach cancer	2.48e-06	3.91e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALB—stomach cancer	2.48e-06	3.9e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CA—stomach cancer	2.47e-06	3.89e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NOS3—stomach cancer	2.37e-06	3.73e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTGS2—stomach cancer	2.17e-06	3.41e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.33e-06	2.1e-05	CbGpPWpGaD
